Cannabis
Village Farms International to Present at Raymond James 42nd Annual Institutional Investors Conference
Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF) (TSX: VFF) today announced that Michael DeGiglio, Chief Executive Officer, and Stephen Ruffini, Chief Financial Officer, will present virtually at the Raymond James 42nd Annual Institutional Investors Conference on Wednesday, March 3, 2021, at 1:20 p.m. ET.
A live webcast of the presentation will be available to the public on Village Farms’ website (www.villagefarms.com) in the Investors section under the Presentations & Events tab. The webcast presentation will be archived and available for 90 days on the Company’s website.
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
Cannabis
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
Cannabis
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Cannabis2 weeks ago
Right on Brands Announces Major Product Line Expansion via HONEY® Brands
-
transfer2 weeks agoIMC to transfer its Oranim Pharmacy shares back to the seller
-
Cannabis1 week ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis1 week ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
CCELL®2 weeks agoCCELL Launches Environmentally Conscious Eco Star AIO Vaporizer
-
Innocan5 days agoInnocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf5 days agoCuraleaf Completes Acquisition of Northern Green Canada
-
Cannabis4 days agoCannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
